About Daniel Gottlieb
Daniel Gottlieb is a director at Cardiosense.
Form D filings also name Daniel Gottlieb as a director at XII Medical.
Daniel Gottlieb reports to the SEC as an officer of 1 public company: Protara Therapeutics (TARA).
Daniel Gottlieb first appears on SEC filings in 2014.
Experience
This experience comes from Daniel Gottlieb's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Gottlieb in the role, so the role may have started earlier or lasted longer.
AM
Alleviant Medical Current
Board of Directors
2025 – Present
CO
CorFlow Current
Board Observer
2024 – Present
Cardiosense, Inc. Current
Board of Directors
2022 – Present · Chicago, IL
Wearable heart pressure monitoring equipment for clinicians treating patients with heart failure.
NM
Nyra Medical Current
Board Observer
2022 – Present
BI
Broadview Ventures Inc Current
Managing Director
2019 – Present
LV
Longview Ventures Current
Director
2019 – Present
CR
CroiValve Current
Board of Directors
2019 – Present
PI
Puzzle Medical Devices Inc.
Board Observer
2022 – 2023
NI
NIDO
Board Observer
2019 – 2022
PI
Protara Therapeutics, Inc.
VP Corporate Development
2014 – 2019 · Public company (TARA)
PT
Proteon Therapeutics
Vice President, Marketing and Corporate Development
2007 – 2019
AV
Abbott Vascular
Strategic Marketing Manager, Endovascular Business Unit
2006 – 2007
GG
Guidant Corporation, Compass Group
Group Manager, Business Development and Corporate Venture Capital (2001 – 2006)
Strategic Planning and Market Research Associate, Coronary Business Unit (1999 – 2001)
1999 – 2006
Key Colleagues at Startups
The people Daniel Gottlieb works with at each company, as listed on that company's latest Form D.
Cardiosense, Inc. · Form D, Aug 24, 2026
BS
Bimal Shah
Director
LF
Lauren Flickinger
Director
Eric Meizlish
Chief Executive Officer and director
Andrew Carek
Co-founder, Chief Technical Officer
JT
Jeffrey Trost
Director
Omer Inan
Co-founder, Chief Scientific Officer and director
XII Medical, Inc. · Form D, Aug 30, 2024
GS
Garrett Schwab
Chief Executive Officer and director
DR
Duke Rohlen
Director
JF
Jd Friedland
Director
SH
Saoussen Ben Halima
Director
SK
Shane Kreidel
Secretary and Chief Financial Officer
RG
Raman Gowri
Director
TN
Tony Natale
Director